The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0% during the forecast period. The increasing demand for advanced medical devices from the aging population and growing healthcare investments in emerging economies are the major drivers for the medical engineered materials market. These factors have increased the demand for advanced healthcare facilities, which is propelling the need for more medical devices, thereby creating growth opportunities for the medical engineered materials market.
Download PDF Brochure https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115477348
The increase in demand for medical engineered materialsand the improving healthcare infrastructure in the emerging economies,such as APAC and South America, are driving the market. The key players in the medical engineered materialsmarket include Evonik (Germany), Covestro (Germany), BASF (Germany), Solvay (Belgium), SABIC (Saudi Arabia), Trelleborg AB (Sweden), DSM (Netherlands), Celanese (US), and DuPont (US).The medical engineered materialsmarket reportanalyzes the key growth strategies, such as investment & expansion, merger & acquisition, agreement & collaboration, partnership, new product launch, adopted by the leading market players between 2018and 2020.
Evonik is a leading advanced chemicals manufacturer involved in the production of bioresorbable polymers, high-performance polymers, PEEK, PA, and PMMA for the medical industry. The expertise of the company in the field of high-performance polymers enabled it to have the opportunity to cater to the changing demands in the medical technology market. Evonik has production plants in 26 countries and has sales presence in more than 100 countries. The company operates in Europe, North America, APAC, South America, Africa, and the Middle East. The company is primarily focused on using organic growth strategy with the new product launch as its key strategy. The consistent development of new products by the company helps it meet the end-use requirements and sustain the global competition.
Covestro is a leading manufacturer and supplier of advanced and high-performance polymers. The company is involved in the continuous development of new solutions to meet volatility in the medical technology markets. Its medical engineering engineered material production units are certified with the environmental management system standard ISO 14001 and the safety management system standard OHSAS 18001. The company follows organic growth strategy to sustain the global competition in the medical plastics engineered materials market. Covestro aims to meet this demand with long-lasting, light, environmentally friendly, and cost-effective materials, which in many cases are suitable replacements for conventional materials such as steel and glass. Consolidation of cross-company activities on a corporate level are expected to enhance long-term development, innovation, digitalization, and strategic development. The company has a strong global presence, with 30 manufacturing sites located in the Americas, Europe, and Asia.